A UK business partnership is bringing health technology to the UK to help HR teams keep staff safe as more businesses return to the office.

Evidence of airborne transmission of Covid-19 is growing. Last month The Centers for Disease Control and Prevention, in the US, stated that ‘airborne virus can be inhaled even when one is more than six feet away from an infected individual’, and at the start of June the BMJ shared upgraded PPE guidance for the NHS ‘as evidence of airborne transmission grows’.

Help in the fight against Covid comes following confirmation that low concentrations of ozone gas can be used to neutralise coronavirus particles without causing harm to humans.

According to scientists from Fujita Health University in Japan, low-level ozone gas in concentrations of 0.05 to 1.0 parts per million (ppm) could be key to neutralising the spread of coronavirus in healthcare settings such as examination rooms and waiting areas. It also provides businesses with an alternative method to sterilise the air and surfaces in their premises and vehicles without the use of chemicals.

Medklinn International, the health technology company that has pioneered research and development into negative ionisation and ozone in the sterilisation process, already provides air and surface sterilisation solutions in Asia, the USA, Canada, Australia and Germany. Now the business has launched in the UK.

Daniel Lu, chief technology and innovation officer of Medklinn International, said: “We are pleased to bring our health technology to the UK. The announcement from the team at Fujita Health University in Japan further demonstrates that ozone sterilisation technology is a viable alternative to the use of chemicals for disinfection.”

Steve Jones, Brand Manager Medklinn UK, said: “We are really excited to launch Medklinn in the UK. Our products are already used by some of the leading global brands including Hyatt, Mandarin Oriental and Singapore’s Changi Airport. We believe that they will be particularly useful as we return to workplaces following the lockdowns over the past 15 months.”

In addition to the latest breakthrough in neutralising coronavirus particles, Medklinn products are also proven to be effective in:

  • killing 99.9% of harmful microorganisms such as viruses and bacteria, mould and fungi by destroying their RNA and DNA structure
  • eliminating volatile organic compounds (VOCs), including those with adverse health effects
  • neutralising allergenic organic compounds such as pet dander and the protein in the faeces of dust mites, which are often the cause of allergies

Medklinn UK offers a range of air and surface sterilisers designed for business use.

By Lisa Baker, Senior Editor

Senior Editor Lisa Baker is the owner of Need to See it Publishing Group, providing contract news for business and news sites across the UK. Lisa is an experienced HR writer and commentator, editing HR publications for more than 5 years.